Summary of Argument
The nation’s leading public-health organizations support Lake and Trumbull Counties because the pharmacies’ over-dispensing of prescription opioids created an ongoing public-health nuisance that cannot be solved simply by ending wrongful conduct today. Ohio—and particularly Lake and Trumbull Counties—has endured staggering overdose rates, with deaths far exceeding national averages and continuing to climb through 2021, contributing to historic declines in U.S. life expectancy. The nation’s largest pharmacy chains flooded these communities with nearly 110 million doses from 2006 to 2019, repeatedly ignoring “red flags” of misuse such as doctor shopping and pharmacy shopping, and choosing profit over their duty to monitor prescriptions. Pharmacists occupy a pivotal position in the opioid supply chain, and their failure to act directly fueled widespread access, dependence, and diversion. Under Ohio law, a public nuisance is an unreasonable interference with public health and safety, and the oversupply of opioids squarely fits this definition. Prescription oversupply did not merely harm individual patients but created a cascade of community-wide effects: widespread addiction, transition to heroin and fentanyl use, unprecedented numbers of overdose deaths, and heavy burdens on hospitals, emergency rooms, first responders, morgues, law enforcement, courts, and jails. The epidemic has driven homelessness, strained foster-care systems, harmed infants born with neonatal abstinence syndrome, and devastated families across racial and socioeconomic lines, with disproportionate impacts on Black, American Indian, and Alaska Native communities. Crucially, stopping oversupply does not remedy these ongoing harms, just as halting toxic discharges does not clean contaminated land. Thousands of residents in these counties now live with opioid-use disorder and require treatment and recovery services. The only adequate remedy is abatement: a court-supervised plan funding proven, evidence-based interventions. Medication-assisted treatment with methadone or buprenorphine reduces overdose deaths, criminal activity, and infectious disease transmission, while expanding access to naloxone saves lives in seconds. Other essential measures include screening and referral programs, maternal and infant care, youth prevention, recovery housing, justice-system supports, stigma reduction, and building an addiction-treatment workforce. Because the pharmacies’ oversupply created a continuing public nuisance that will persist without meaningful intervention, the Court should affirm the district court’s judgment and uphold an abatement remedy that empowers local governments to fund treatment, prevention, and recovery, and to repair the extensive harms caused by the opioid epidemic.